Your Subscription

We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.





Login
Twitter LinkedIn




Login
  • Home
  • About
  • Updates
  • Awards
  • Contact
  • Directory
  • OnDemand
  • Partners
  • Testimonials
Forward Share Print
Sidley Austin LLP

Medicare Advantage providers pay $5 million to settle False Claims Act allegations

Newsletters

11 September 2019

Healthcare & Life Sciences USA

On 8 August 2019 Beaver Medical Group LP and a Beaver-affiliated physician, Dr Sherif Khalil, agreed to pay a combined total of $5 million to resolve allegations that the providers had knowingly submitted diagnosis codes that were not supported by the medical records in order to inflate reimbursements from Medicare. The qui tam action was brought by a former Beaver employee, Dr David Nutter, and the Department of Justice (DOJ) intervened.

The settlement reflects the DOJ's continuing efforts to use its enforcement power to pursue fraud in the Medicare Advantage space despite recent setbacks in UnitedHealthcare Insurance Co v Azar,(1) which vacated a portion of the Centre for Medicare and Medicaid Services' 2014 final overpayment rule applicable to the Medicare Advantage programme (for further information please see "Court vacates Medicare Advantage overpayment rule and curtails DOJ's pursuit of False Claims Act damages"). Indeed, in its press release, the DOJ emphasised that preventing Medicare Advantage fraud remains a top priority:

As enrollment in Medicare Advantage continues to grow, investigation into accuracy of diagnosis data becomes ever more important… Those who inflate bills sent to government health programs can except to pay a heavy price.(2)

For further information on this topic please contact Jaime LM Jones or Jennifer Haney at Sidley Austin LLP by telephone (+1 202 736 8000) or email (jaime.jones@sidley.com or jhaney01@sidley.com). The Sidley Austin LLP website can be accessed at www.sidley.com.

Endnotes

(1) 330 F Supp 3d 173 (DDC 2018).

(2) The DOJ's press release is available here.

The materials contained on this website are for general information purposes only and are subject to the disclaimer.

ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.

Forward Share Print

Authors

Jaime L M Jones

Jaime L M Jones

Jennifer M Haney

Jennifer M Haney

Register now for your free newsletter

View recent newsletter

More from this firm

  • Ninth Circuit invited to weigh in on public disclosure bar falsity
  • DOJ defends Medicare Advantage upcoding claims against Sutter
  • Government will allow broader use of co-pay accumulator programmes for 2020
  • Sutter Health files motion to dismiss, criticising DOJ's outdated False Claims Act theories in Medicare Advantage case
  • Lethal injection opinion from DOJ OLC threatens FDA's claims-based interpretation of 'intended use'

More articles

  • Home
  • About
  • Updates
  • Awards
  • Contact
  • My account
  • Directory
  • OnDemand
  • Partners
  • Testimonials
  • Follow on Twitter
  • Follow on LinkedIn
  • Disclaimer
  • Privacy policy
  • GDPR Compliance
  • Terms
  • Cookie policy
Online Media Partners
Inter-Pacific Bar Association (IPBA) International Bar Association (IBA) European Company Lawyers Association (ECLA) Association of Corporate Counsel (ACC) American Bar Association Section of International Law (ABA)

© 1997-2021 Law Business Research

You need to be logged in to make a comment. Log in here.
Many thanks. Your comment has been sent.

Your details



Your comment or question *